glp-1 substitute Natural Alternatives: Supporting Metabolic Health Comparing Ozempic, Wegovy and Other

Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor) Disease area(s): Respiratory/rare disease Manufacturer(s): Vertex Pharmaceuticals Incorporated 2024 Sales (USD): $10.24 billion Why it sold so well: Trikafta (marketed as Kaftrio outside the US), a combination therapy of elexacaftor, tezacaftor and ivacaftor, was the primary driver of Vertex Pharmaceuticals strong commercial performance in 2024

While your body's natural GLP-1 and pharmaceutical GLP-1 receptor agonists share the same basic mechanism of action, there are important differences in their structure, duration of effect, and clinical applications

This leads to reduced hunger, better portion control, and steady fat loss

Because these medications work in different ways, making the switch takes some planning, and your doctor will help guide the process